Related Experiment Video
Updated: Mar 12, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia
Liya Ma1, Ping Zhou1, Josef Neu2
1Department of Neonatology, Shenzhen Baoan Maternal and Child Health Hospital, China.
Insights
Certain nutrients like vitamin A and long-chain polyunsaturated fatty acids (LCPUFAs) show promise in preventing bronchopulmonary dysplasia (BPD) in preterm infants. Further research is needed to explore other nutrients for BPD prevention and treatment.
Area of Science:
- Neonatal Medicine
- Nutritional Science
- Pulmonology
Background:
- Bronchopulmonary dysplasia (BPD) is a common complication in extremely preterm infants.
- Current incidence of BPD remains high despite medical advancements, with a lack of specific treatments.
- Nutrition is critical for lung development, and malnutrition can exacerbate BPD pathogenesis.
Purpose of the Study:
- To review recent research on nutrients that may prevent or treat BPD.
- To identify specific nutrients with potential therapeutic benefits for BPD.
Main Methods:
- Literature review of studies investigating the role of various nutrients in BPD.
- Analysis of evidence for nutrients including glutamine, cysteine, L-arginine, L-citrulline, LCPUFAs, inositol, selenium, and vitamins.
Main Results:
- Vitamin A and LCPUFAs demonstrate potential in preventing BPD.
- L-citrulline may offer a treatment for BPD-associated chronic pulmonary hypertension.
- Evidence for other nutrients in BPD prevention requires further investigation.
Conclusions:
- Specific nutrients, particularly vitamin A and LCPUFAs, show promise for BPD prevention.
- L-citrulline presents a potential therapeutic avenue for BPD complications.
- Additional research is necessary to fully elucidate the role of various nutrients in managing BPD.
Abstract:
Bronchopulmonary dysplasia (BPD) is a frequent complication occurring in extremely preterm infants. Despite recent advances in newborn medicine, the incidence of BPD does not appear to have changed markedly, and specific treatments and prevention strategies are still lacking. Nutrition plays an important role in normal lung development and maturation. Malnutrition may delay somatic growth and new alveoli development, thus aggravating pulmonary injury involved in the pathogenesis of BPD. However, few nutrients have been investigated for their potential to mitigate the pathogenesis of BPD. In this article, we reviewed the recent progress in research on potential nutrients useful for the prevention or treatment of BPD, including glutamine, cysteine and N-acetylcysteine, L-arginine and L-citrulline, long chain polyunsaturated fatty acids (LCPUFAs), inositol, selenium, and some antioxidant vitamins including vitamin A. Current evidence shows that vitamin A and LCPUFA can prevent BPD, and that L-citrulline might provide a new method to treat chronic pulmonary hypertension associated with BPD in premature infants. The effects of other nutrients on BPD prevention need to be further studied.
More Related Videos
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Breathing
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
COPD: Management Using Bronchodilators and Corticosteroids

